New chemotypes for cathepsin K inhibitors

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Drug Discovery

Background:

• Cathepsin K is a key cysteine protease implicated in bone resorption and osteoporosis.
• Developing selective inhibitors for cathepsin K is crucial for therapeutic intervention.
• Homologous cathepsins L and S can present challenges in achieving target selectivity.

Purpose of the Study:

• To synthesize and evaluate novel chemical entities as potential inhibitors of cathepsin K.
• To explore new chemotypes for the development of cathepsin K inhibitors.
• To assess the inhibitory activity against cathepsin K and related cathepsins L and S.

Main Methods:

• Synthesis of novel cyano pyrimidine acetylene and cyano pyrimidine t-amine derivatives.
• In vitro enzymatic assays to determine inhibitory activity against cathepsin K.
• Testing against highly homologous cathepsins L and S to assess selectivity.

Main Results:

• Successfully prepared novel cyano pyrimidine acetylene and cyano pyrimidine t-amine compounds.
• Demonstrated inhibitory activity of these new chemical classes against cathepsin K.
• Initial data suggests potential for these compounds as cathepsin K inhibitors, with derivatives of compounds 1 and 8 showing promise.

Conclusions:

• The study introduces a new class of chemical compounds with potential as cathepsin K inhibitors.
• Novel chemotypes have been identified and demonstrated for the development of cathepsin K inhibitors.
• Further investigation into these derivatives may lead to the development of targeted therapies for cathepsin K-related diseases.